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Matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) is emerging in laborato-
ries as a new diagnostic tool for microorganism identification. We prospectively compared the performances of the Biflex
III-Biotyper (Bruker Daltonics) and the Axima (Shimadzu)-SARAMIS (AnagnosTec) systems for the identification of 312
yeasts isolated from clinical specimens (249 Candida spp., including 19 C. albicans and 230 non-albicans species and 63
isolates belonging to different species of the genera Saccharomyces [20 isolates], Rhodotorula [8 isolates], Cryptococcus [8
isolates], Trichosporon [7 isolates], Pichia [7 isolates], Geotrichum [12 isolates], and Sporopachydermia cereana [1 iso-
late]). Species were identified by using routine conventional phenotypical methods and internal transcribed spacer (ITS)
sequencing in case of discrepancy. We used expanded thresholds for species identification (log score of>1.7 with 3 identi-
cal consecutive propositions and no discrepancy between the duplicates for the Bruker Daltonics system and similitude of
>40% with 5 successive identical propositions and no discrepancy between the duplicates for the Shimadzu system). Of
the 312 isolates, 272 (87.2%) and 258 (82.7%) were successfully identified by the Bruker Daltonics and Shimadzu systems,
respectively. All isolates were successfully identified within the most frequent and clinically relevant Candida species by
the two systems. Nonvalid results corresponded mainly to species not or poorly represented in the databases. Major mis-
identifications were observed for 2 isolates (0.6%) by the Bruker Daltonics system and 4 isolates (1.3%) by the Shimadzu
system. In conclusion, the performances of the Bruker Daltonics and the Shimadzu systems for yeast identification were
good and comparable under routine clinical conditions, despite their differences in sample preparation, database content,
and spectrum analysis.
Over the past few years, the incidence of fungal infectionshas considerably increased, especially in critically ill and
immunocompromised patients. Yeast infections are the most
frequent and are a major cause of morbidity and mortality.
Between 1979 and 2000, the number of annual cases of funge-
mia increased by 207% in the United States (1). Candida spe-
cies are the 4th cause of nosocomial bloodstream infection and
are associated with a high mortality rate (2). Many studies
demonstrated that rapid initiation of appropriate antifungal
therapy is crucial to reducing mortality (3, 4). The susceptibil-
ity to antifungal molecules varies depending on the genus and
the species. If Candida albicans remains the most frequent
bloodstream fungal pathogen, but non-albicans species are in-
creasing and are associated with variable susceptibility profiles
to antifungal drugs (5). Recently, new cryptic Candida species
were described (i.e.,C. metapsilosis andC. orthopsilosis in theC.
parapsilosis complex or C. nivariensis and C. bracarensis in the
C. glabrata complex), species that conventional phenotypic
identification methods cannot identify (6, 7). Additionally, in-
vasive infections due to the less frequent and naturally resistant
to echinocandins species of the genera Cryptococcus, Tricho-
sporon, Malassezia, and Rhodotorula have been observed (8).
Except for C. albicans, which can be directly identified on chro-
mogenic media, and Candida glabrata and Candida krusei,
which can be identified by rapid enzymatic and latex aggluti-
nation methods, conventional phenotypic methods used for
routine identification of other species are time-consuming,
costly, and lack accuracy for less frequent or cryptic species.
Recently, matrix-assisted laser desorption ionization–time
of flight mass spectrometry (MALDI-TOF MS) was applied to
microorganism identification and emerged in laboratories as a
large-scale retail and new diagnostic tool. Several studies have
reported good performances of MALDI-TOF MS for Candida
identification, allowing accurate, rapid, and cost-effective re-
sults (9–12).
Among the systems available, the Shimadzu system (Shi-
madzu-Biotech Corp., Kyoto, Japan) and the Bruker Daltonics
system (Bruker, Bremen, Germany) are the most frequently used.
We prospectively compared the performances of the Bruker Dal-
tonics Biflex III spectrometer with its database, Biotyper, to the
Shimadzu Axima spectrometer with its database, SARAMIS
(AnagnosTec, Potsdam-Golm, Germany), for identification of
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yeasts isolated from clinical specimens with a large range of spe-
cies, including less common non-albicans Candida species and
non-Candida species.
MATERIALS AND METHODS
Yeast isolates. All isolates were prospectively selected from positive cul-
tures obtained from routine clinical specimens (blood samples, urine and
stool specimens, mouth washes, respiratory tract samples, vaginal swabs,
catheters, and peritoneal and pleural fluids) analyzed in the Mycological
Laboratory of the Strasbourg University Hospital, Strasbourg, France, be-
tweenNovember 2009 and June 2010. Altogether, this study included 312
isolates corresponding to 249 isolates of Candida spp. (19 C. albicans and
230 non-albicans species) and 63 isolates of non-Candida species (20 Sac-
charomyces cerevisiae, 8 Rhodotorula mucilaginosa, 8 Cryptococcus neofor-
mans, 7 isolates of the Trichosporon genus, 7 isolates of the Pichia genus, 6
Geotrichum candidum, 6 G. capitatum, and 1 Sporopachydermia cereana).
Geotrichum isolates were included as they may present yeast-like colonies
and are therefore initially identified using laboratory methods applied to
yeast identification.
Conventional identification. The isolates, primary isolated on the
chromogenic medium chromID Candida (bioMérieux), were prospec-
tively identified using phenotypic and, if necessary, molecular methods
according to the routine diagnostic flow of the laboratory: C. albicanswas
directly identified by its shiny blue colonies on the chromogenicmedium;
colonies with presumptive identification ofCandida glabrata (shiny white
colonies) or Candida krusei (flat and dried white colonies) were tested
using the enzymatic test Glabrata RTT (Fumouze) and the latex test Kru-
sei-color (Fumouze), respectively. The other isolates were identified using
the Auxacolor 2 (Bio-Rad) yeast identification system in combination
with a microscopic morphological study on potato-carrot-bile medium
(Bio-Rad). In case of failure or discrepancy between phenotypic andmor-
phological characters, the isolates were retested using the phenotypic API
ID 32C system (bioMérieux). If necessary, identification was confirmed
by molecular identification as described below.
Molecular identification. Double-strand sequencing of the ribo-
somal internal transcribed spacer (ITS) DNA 5.8S region using ITS1
(TCCGTAGGTGAACCTGCGG) and ITS4 (TCCTCCGCTTATTGATA
TGC) primers was adapted from reference 13. Sequences were analyzed
with BLAST software against the GenBank EMBL, DDBJ, and PDB data-
bases, and the results were confirmed against the CBS database.
Subculture before MALDI-TOF analysis. All of the isolates were sub-
cultured on Sabouraud chloramphenicol dextrose agar (Oxoid) and/or
on chromID Candidamedium at 35°C, except for Rhodotorula and Cryp-
tococcus isolates, which were incubated at 27°C. After 48 h of incubation,
all isolates were simultaneously identified using the two spectrometers. In
case of nonidentification, a second analysis was done after a new extrac-
tion, in order to proceed under conditions comparable to those in routine
diagnostic flow.
MALDI-TOF Biflex III (Bruker Daltonics). According to the manu-
facturer’s recommendations, one or two colonies were suspended in 1 ml
of 70% ethanol (Carbo Erba reagents) in an Eppendorf microtube, briefly
vortexed, and centrifuged for 2 min at 13,000  g. The supernatant was
removed, a second centrifugation of 30 s at 13,000 gwas performed, and
the rest of supernatant was removed using a pipette. The pellet was resus-
pended in 50 l of formic acid (70% [vol/vol]) (AnalaR Normapur), and
50 l of acetonitrile (Sigma-Aldrich) was added. After 15 min of incuba-
tion at room temperature, the mixture was centrifuged for 2 min at
13,000  g and 1 l of the supernatant was applied in duplicate onto a
steel target plate and allowed to dry at room temperature. Afterwards, 1l
of matrix solution was applied to the spot and allowed to dry at room
temperature. The matrix solution was freshly prepared with -cyano-4-
hydroxyl-cinnaminic (CHCA) powder in 500 l of acetonitrile (Sigma-
Aldrich) and 500 l of 5% trifluoroacetic acid solution. Each specimen
was analyzed in duplicate.
Measurements were performed with a MALDI-TOF Biflex III sys-
tem (Faculty of Medicine, University of Strasbourg, France). Protein
mass fingerprints were recorded in linear positive mode at a laser
frequency of 20 Hz within a mass range from 2 to 20 kDa. The ioniza-
tion source was fitted out with a delayed extraction time of 400 ns.
Each spectrum was obtained from 240 shots in 40-shot steps from
different positions on the target plate. The system was calibrated be-
fore each analysis using a strain of Escherichia coliDH5. Each spectrum
was transferred to the Biotyper software and compared to the Maldi
Biotyper DB database version 2.0.4.0, analyzed by the software-de-
fined algorithm, resulting in a logarithm score from 0 to 3. According
to the manufacturer’s recommendations, species identification is valid
for a score superior to 2.0, while a score of 1.7 to 2.0 identifies the
genus.We used a lower threshold and considered species identification
for scores from 1.7 with 3 identical successive propositions of identi-
fication and no discrepancy between two replicates. These expanded
thresholds were previously validated in preliminary experiments con-
ducted on 65 isolates belonging to 9 different common species that
provided 92% of correct species identifications using the manufactur-
er’s threshold recommendations and 100% of correct species identifi-
cations without any misidentification using the expanded threshold.
MALDI-TOF Axima (Shimadzu).One colonywas suspended in 20l
of 25% formic acid (Sigma-Aldrich). After 2 to 3 min at room tempera-
ture, the mixture was vortexed and 1 l was applied in duplicate onto a
steel target plate and allowed to dry at room temperature. Then, 1 l of
CHCA matrix solution (AnagnosTec) was added to the spot and allowed
to dry at room temperature.
Measurements were performed using aMALDI-TOF Axima system
(Microbiology Laboratory of the Mulhouse Hospital, France). The
laser frequency was 50 Hz, the acceleration voltage was 20 kV, and
the extraction delay time was 200 ns. The spectra were recorded in the
linear positive mode within a mass range of 3 to 20 kDa. Each plate was
calibrated and validated with a control strain of E. coli CGU 10979,
tested at the beginning and at the end of the use of each plate. All mass
fingerprints were analyzed by the SARAMIS software, which first com-
pares them to the superspectra and in a second step to the individual
spectra of the database AnagnosTec version 4.07. The results are ex-
pressed in percentages of similitude. Superspectra contain peaks com-
mon to different strains of the same species. Individual spectra corre-
spond to spectra of each strain cultured in specific conditions. The
manufacturer recommends validation of only the superspectra identi-
fications with percentages comprising between 75 and 99.9%. We ex-
panded the species identification to individual spectra with percent-
ages of similitude above 40%, 5 successive identical propositions, and
no discrepancy between the duplicates. These expanded thresholds
were previously validated in preliminary experiments conducted on 65
isolates belonging to 9 different common species that provided 88% of
correct species identifications using the manufacturer’s threshold rec-
ommendations and 100% of correct species identifications without
any misidentification using the expanded threshold.
Analysis. Definite species identification was considered when routine
identification methods and the two MALDI-TOF systems gave the same
result. In the case of discrepant results, ITS sequencingwas performed and
this result was considered the reference identification.
RESULTS
Conventional methods. Based on the criteria defined above, first-
line routine methods gave a definite species identification for 289
of the 312 isolates (92.6%). Twenty-three (7.4%) were misidenti-
fied, mainly concerning species closely related, and then were re-
identified by ITS sequencing (Table 1).
MALDI-TOF Biflex III-BioTyper (Bruker Daltonics). Of the
312 isolates included, 272 (87.2%) were successfully identified
(Table 2). All isolates were successfully identified within the clin-
ically most common Candida species (C. albicans, C. glabrata, C.
tropicalis, C. parapsilosis, C. krusei, C. kefyr, C. guilliermondii, and
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C. lusitaniae) and S. cerevisiae. MALDI-TOF enabled identifica-
tion of some very closely related species, indistinguishable by con-
ventional phenotypic methods, including, C. pararugosa (7 of the
8 isolates) andC. orthopsilosis (2 isolates), misidentified by con-
ventional phenotypic methods as C. rugosa and C. parapsilosis,
respectively. All 7 isolates of C. dubliniensis were successfully
identified. Eight isolates were identified as P. cactophila, which
is considered conspecific with C. inconspicua (14); such iden-
tification results were also observed in other studies (15, 16).
These 8 isolates were reidentified by ITS sequencing and were
confirmed as C. inconspicua species, so we considered them
valid identifications.
Among the remaining 40 isolates detailed in Table 3, the cor-
rect identification was proposed by the system for 18 isolates, but
with an insufficient score,1.7. All of these isolates were species
poorly represented in the database (less than 5 spectra per spe-
cies). Twenty isolates were not identified because the species were
either absent from the database (18 isolates) or poorly represented
(2 isolates). Finally, 2 (0.6%)Trichosporon isolateswere reallymis-
identified: oneT. asahii isolate and oneT. inkin isolate, both iden-
tified as T. cutaneum.
MALDI-TOF Axima-SARAMIS (Shimadzu-AnagnosTec).
Of the 312 isolates analyzed, 258 (82.7%) were successfully iden-
tified (Table 2). Again, all isolates of C. albicans, C. glabrata, C.
tropicalis, C. parapsilosis, C. krusei, C. kefyr, C. guilliermondii, C.
lusitaniae, C. dubliniensis, and S. cerevisiaewere successfully iden-
tified. Fifty-five isolates (17.3%) did not have a valid result (Table
4). Among them, the correct identification but with insufficient
score (percentage of 40%) was proposed by the system for 9
isolates, despite a significant representation in the AnagnosTec
database. Forty-one isolates were not identified, 37 belonging to
species absent from (28 isolates, including C. inconspicua and C.
pararugosa) or poorly represented in (less than 2 superspectra and
less than 10 spectra per species) (9 isolates) the database. Four
isolates were not identified despite a correct representation in the
database. Finally, 4 isolates were misidentified, 3 of them corre-
sponding to species not present in the database—C. orthopsilosis
(2 isolates identified as C. parapsilosis) and P. carpophila (1 isolate
identified as C. guilliermondii).
DISCUSSION
The aim of this study was to evaluate and compare the perfor-
mances of the Biflex III-Biotyper (Bruker Daltonics) system to
the Axima-SARAMIS (Shimadzu-AnagnosTec) system for
MALDI-TOF prospective identification of a large panel of
yeasts isolates from clinical specimens, including frequent and
rare species and Candida and non-Candida species. The per-
centages of correctly identified isolates were comparable be-
tween the two MALDI TOF systems (Bruker Daltonics system,
87.2%; Shimadzu system, 82.7%). The majority of the isolates
with no identification or with a correct identification associ-
ated with an insufficient score corresponded to species either
absent from or poorly represented in the databases at the time
of the study. Updated versions of the databases now available
have been completed for some but not all of the nonidentified
isolates of our study.
The numbers of major errors (misidentifications) were
low for the two MALDI-TOF systems (0.6% for the Axima-
SARAMIS and 1.3% for the Biflex III-Biotyper) compared to
conventional methods (7.4%). With the Axima-SARAMIS sys-
tem, 3 of the 4 errors concerned closely related species not or
poorly represented in the database (2 C. orthopsilosis isolates
and 1 P. carpophila isolate identified as C. parapsilosis and C.
guilliermondii, respectively). Santos et al. have obtained good
results for the C. parapsilosis complex by adding spectra of C.
orthopsilosis and C. metapsilosis to the AnagnosTec database
(11). P. carpophila is a recently described species very close to
C. guilliermondii and C. caribbica (17).
The identification performance was lower for Basidiomyce-
tes of the genera Cryptococcus and Trichosporon and for Geotri-
chum capitatum, perhaps related to the relatively low represen-
tation of these genera and species in the two databases or due to
the particular composition of their cell wall, very rich in exter-
nal sugars, making protein extraction more difficult. These dif-
TABLE 1 Misidentifications by the conventional phenotypic methods
Molecular identification No. of isolates
Conventional phenotypic identification
Cause of misidentificationbMisidentification Methoda
Candida pararugosa 7 Candida rugose PCB/Auxa/ID32C ND no phenotypic differences
Pichia carpophila 2 Candida guilliermondii PCB/Auxa/ID32C ND no phenotypic differences
Pichia caribbica 1 Candida guilliermondii PCB/Auxa/ID32C ND no phenotypic differences
Candida orthopsilosis 2 Candida parapsilosis PCB/Auxa ND no phenotypic differences
C. dubliniensis 1 Candida albicans chromID Candidamedia Similar to C. albicans on chromID Candidamedia
Pichia guilliermondii 1 Candida famata PCB/Auxa/ID32C Error
Candida sphaerica 1 Candida lusitaniae PCB/Auxa Error
Candida utilis 1 Candida pelliculosa PCB/Auxa/ID32C Error
Pichia burtonii 1 Candida sake PCB/Auxa/ID32C ND
Candida aaseri 1 Candida sake PCB/Auxa/ID32C ND
Pichia fabianii 1 Candida utilis PCB/Auxa/ID32C ND
Trichosporon asahii 1 Trichosporon inkin PCB/Auxa Error
Trichosporon inkin 1 Trichosporon asahii PCB/Auxa Error
T. cutaneum 1 Trichosporon mucoides PCB/Auxa ND
Sporopachydermia cereana 1 Candida boidinii PCB/Auxa/ID32C ND
a PCB, microscopic morphology on potato-carrot-bile medium; Auxa, Auxacolor 2 system; ID32C, API ID32C system.
b ND, species not present in the phenotypic database. “No phenotypic differences” indicates there are no phenotypic differences between the species according to macroscopic,
microscopic, and phenotypic characteristics. “Error” indicates misidentification despite the presence of the species in the phenotypic database.
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TABLE 2 Distribution of MALDI-TOF results for species identifications obtained by the Biflex III-Biotyper and Axima-SARAMIS systems
Species
No. of
isolates
No. of isolates with result by:
Biflex III-Biotyper Axima-SARAMIS
Valid IDa
Correct species
ID score of1.7 No ID
False species
ID Valid ID
Correct species ID
score of40% No ID
False species
ID
Candida
C. aaseri 1 0 0 1 0 1 0 0 0
C. albicans 19 19 0 0 0 19 0 0 0
C. blankii 1 0 0 1 0 0 0 1 0
C. boidinii 1 1 0 0 0 1 0 0 0
C. catenulata 2 0 2 0 0 2 0 0 0
C. ciferrii 1 0 1 0 0 1 0 0 0
C. colliculosa 1 0 1 0 0 0 0 1 0
C. dubliniensis 7 7 0 0 0 7 0 0 0
C. famata 2 0 1 1 0 1 0 1 0
C. glabrata 26 26 0 0 0 26 0 0 0
C. guilliermondii 16 16 0 0 0 16 0 0 0
C. haemulonii 1 1 0 0 0 0 0 1 0
C. holmii 1 0 0 1 0 0 0 1 0
C. inconspicua 8 8 0 0 0 0 0 8 0
C. intermedia 2 1 1 0 0 0 0 2 0
C. kefyr 23 23 0 0 0 23 0 0 0
C. krusei 22 22 0 0 0 22 0 0 0
C. lipolytica 9 9 0 0 0 9 0 0 0
C. lusitaniae 23 23 0 0 0 23 0 0 0
C. norvegensis 9 9 0 0 0 9 0 0 0
C. orthopsilosis 2 2 0 0 0 0 0 0 2
C. parapsilosis 28 28 0 0 0 28 0 0 0
C. pararugosa 8 7 1 0 0 0 0 8 0
C. pelliculosa 1 1 0 0 0 0 1 0 0
C. pulcherrima 2 2 0 0 0 1 1 0 0
C. sphaerica 3 0 0 3 0 0 0 3 0
C. tropicalis 24 24 0 0 0 24 0 0 0
C. utilis 6 6 0 0 0 6 0 0 0
Cryptococcus neoformans 8 5 3 0 0 3 5 0 0
Pichia
P. burtonii 1 0 0 1 0 0 0 1 0
P. caribbica 1 0 0 1 0 0 0 1 0
P. carpophila 2 0 0 2 0 0 0 1 1
P. fabianii 1 0 0 1 0 0 0 1 0
P. farinosa 1 0 1 0 0 1 0 0 0
P. ohmeri 1 1 0 0 0 0 0 1 0
Rhodotorula mucilaginosa 8 7 1 0 0 8 0 0 0
Saccharomyces cerevisiae 20 20 0 0 0 20 0 0 0
Sporopachydermia
cereana
1 0 0 1 0 0 0 1 0
Trichosporon
T. asahii 2 1 0 0 1 0 0 2 0
T. cutaneum 1 0 0 1 0 0 0 1 0
T. inkin 1 0 0 0 1 0 0 0 1
T. mucoides 3 3 0 0 0 3 0 0 0
Geotrichum
G. candidum 6 0 6 0 0 4 2 0 0
G. capitatum 6 0 0 6 0 0 0 6 0
Total no. (%) 312 (100) 272 (87.2) 18 (5.8) 20 (6.4) 2 (0.6) 258 (82.7) 9 (2.9) 41 (13.1) 4 (1.3)
a ID, identification.
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ficulties in identification were reported by other studies using
the manufacturers’ standard databases (9, 10, 18, 19). Good
performances were obtained for Cryptococcus by enriching the
databases (20, 21). Of the 6 Trichosporon isolates tested, 3 iso-
lates of T. mucoides were correctly identified by both systems,
but T. asahii, T. inkin, and T. cutaneum posed problems of
nonidentification or misidentification as other species of the
genus Trichosporon. All of the species tested were present in
both databases, but only T. mucoides and T. asahii were well
represented. For the latter, the identification problems could
be related to the drier texture of the colonies, which makes it
difficult to achieve homogeneous spots for analysis.
In the literature, a few studies evaluated the use of theMALDI-
TOF method for yeast identification, reporting performances
from 87 to 97.5% by using the manufacturers’ extraction and val-
idation recommendations on the Bruker Daltonics system (9, 10,
12, 15, 19, 22) and from 94.5 to 96.1% with the Shimadzu system
(15, 23), depending on the panel of yeasts tested (especially for the
presence of Cryptococcus, Geotrichum, and Trichosporon in the
panel), the version of the database, and on the analysis’s inclusion
or noninclusion of the nonrepresented species in the database. In
the Bruker Daltonics systems, these percentages increased to 96.3
to 98.4%withoutmoremisidentifications when a validation score
of 1.8 or 1.7 was used (12, 16, 19, 22).
Bader et al. compared the two systems on 1,192 isolates
representing 32 species and also described comparable perfor-
mances between the two systems, with 97.6 and 96.1% of cor-
rect identifications on the Bruker Daltonics system and the
Shimadzu system, respectively (15). These performances are
higher than those in our study, probably due to the yeast panel
included, since 93% of the isolates were common species (C.
albicans, C. glabrata, C. parapsilosis, C. tropicalis, C. krusei, C.
kefyr, C. lusitaniae, and S. cerevisiae) for which the identifica-
tion performances are very good. In our study, these species
represented only 59% of the isolates tested and were all cor-
rectly identified by the two systems.
In conclusion, the performances of the Bruker Daltonics
and the ShimadzuMALDI-TOF systems for yeast identification
were good when performed under routine clinical conditions,
despite their differences in sample preparation, database con-
tent, and spectrum analysis. Compared to biochemical tech-
niques, mass spectrometry is easier, faster, cheaper, and more
accurate, allowing identification of closely related species in-
distinguishable by conventional phenotypic methods. In the
future, enrichment of databases should improve identification
of rare species and Basidiomycetes. In parallel, works are in
progress for the preanalytical extraction step, and improved
and shorter protocols have been recently proposed as alterna-
tives to the standard procedures recommended by the manu-
facturers (16, 24, 25).
TABLE 3 Distribution of the discrepancies observed in the Biflex III-Biotyper system
Nature of discrepancy (no. of isolates)
Representation of species in
database (no. of isolates) Isolates (no.)
False species (2) Well represented (2) T. inkin (1),a T. asahii (1)a
Correct species with insufficient score (18) Weakly represented (18) G. candidum (6), C. neoformans (3), C. catenulata (2),
C. ciferii (1), C. colliculosa (1), C. famata (1), C.
intermedia (1), C. pararugosa (1), P. farinosa (1), R.
mucilaginosa (1)
No identification (20) Not represented (18) G. capitatum (6), C. sphaerica (3), P. carpophila (2), P.
caribbica (1), C. aaseri (1), C. blankii (1), C. holmii
(1), P. burtonii (1), P. fabianii (1), S. cereana (1)
Weakly represented (2) C. famata (1), T. cutaneum (1)
a Identified as T. cutaneum.
TABLE 4 Distribution of the discrepancies observed in the Axima-SARAMIS system
Nature of discrepancy (no. of isolates)
Representation of species in
database (no. of isolates) Isolates (no.)
False species (4) Not represented (3) C. orthopsilosis (2),a P. carpophila (1),b
Well represented (1) T. inkin (1)c
Correct species with insufficient score (9) Well represented (9) C. neoformans (5), C. pulcherrima (1), C. pelliculosa (1), G.
candidum (2)
No identification (41) Not represented (28) C. inconspicua (8), C. pararugosa (8), C. sphaerica (3), C. blankii
(1), C. colliculosa (1), C. holmii (1), P. burtonii (1), P.
caribbica (1), P. carpophila (1), P. fabianii (1), P. ohmeri (1),
Sporopachydermia cereana (1)
Weakly represented (9) G. capitatum (6), C. intermedia (2), C. haemulonii (1)
Well represented (4) T. asahii (2), T. cutaneum (1), C. famata (1)
a Identified as C. parapsilosis.
b Identified as C. guilliermondii.
c Identified as T. asahii.
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